Company and Business Model

Benostan develops and commercializes novel preclinical assets in a topical form focusing on Women’s Health, Gynecology and Dermatology. As an emerging OTC consumer goods company, is engaged in the Research, Development, and Licensing of non-prescription medicine and consumer Self Care products

Our products are marketed to patients, pharmacies and physicians. The marketing mix and target groups differ between countries, depending on the degree to which patients individually make decisions about their treatment

We collaborate with pharmaceutical companies covering more than 40 countries with a total of 2 billion inhabitants. Our most significant markets are currently in South East Asia, North Africa and the Middle East countries, as well as Central America